CA9 and neoplasm: Taken together, we have validated the use of FMT imaging with a selective, NIR fluorescent CA IX inhibitor for non-invasive quantification of CA IX expression as an indicator of tumor hypoxia in live animals bearing CA IX positive tumor xenografts.